VA
GILD icon

Valmark Advisers’s Gilead Sciences GILD Stock Holding History

Valmark Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$412K Sell
3,261
-22
-0.7% -$2.9K ﹤0.01% 547
2026
Q1 		$458K Buy
3,283
+130
+4% +$18.2K 0.01% 486
2025
Q4 		$387K Sell
3,153
-19
-0.6% -$2.31K ﹤0.01% 497
2025
Q3 		$352K Sell
3,172
-213
-6% -$24.2K ﹤0.01% 510
2025
Q2 		$375K Sell
3,385
-1
-0% -$106 0.01% 493
2025
Q1 		$379K Sell
3,386
-105
-3% -$10.8K 0.01% 472
2024
Q4 		$322K Sell
3,491
-64
-2% -$5.76K 0.01% 495
2024
Q3 		$298K Sell
3,555
-618
-15% -$47.2K ﹤0.01% 502
2024
Q2 		$286K Buy
4,173
+384
+10% +$25.6K ﹤0.01% 481
2024
Q1 		$278K Sell
3,789
-447
-11% -$34.4K ﹤0.01% 467
2023
Q4 		$343K Sell
4,236
-726
-15% -$56.5K 0.01% 402
2023
Q3 		$372K Sell
4,962
-79
-2% -$6.08K 0.01% 369
2023
Q2 		$389K Buy
5,041
+82
+2% +$6.54K 0.01% 366
2023
Q1 		$411K Buy
4,959
+98
+2% +$8.12K 0.01% 347
2022
Q4 		$417K Buy
4,861
+618
+15% +$48.9K 0.01% 331
2022
Q3 		$262K Sell
4,243
-25
-0.6% -$1.58K 0.01% 366
2022
Q2 		$264K Sell
4,268
-17
-0.4% -$1.05K 0.01% 365
2022
Q1 		$255K Sell
4,285
-316
-7% -$20.2K ﹤0.01% 388
2021
Q4 		$334K Sell
4,601
-694
-13% -$47.8K 0.01% 332
2021
Q3 		$370K Sell
5,295
-171
-3% -$12K 0.01% 301
2021
Q2 		$376K Buy
5,466
+9
+0.2% +$601 0.01% 305
2021
Q1 		$353K Buy
5,457
+1,366
+33% +$88.1K 0.01% 304
2020
Q4 		$238K Buy
+4,091
New +$247K ﹤0.01% 321

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Valmark Advisers's GILD Position: Q2 2026 in Review

Valmark Advisers reduced its Gilead Sciences (GILD) stake by 0.67% in Q2 2026, selling an estimated $2.9K and leaving 3,261 shares worth $412K. The position accounts for ﹤0.01% of the portfolio, ranked #547.

Valmark Advisers first reported a position in GILD in Q4 2020 and has held it in 23 quarters since. The position peaked at $458K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Valmark Advisers held 3,261 shares of Gilead Sciences worth $412K as of Q2 2026.
  • Valmark Advisers sold 22 Gilead Sciences shares in Q2 2026, an estimated $2.9K.
  • Gilead Sciences made up ﹤0.01% of Valmark Advisers's portfolio in Q2 2026, its #547 holding.
  • Valmark Advisers first reported a position in Gilead Sciences in Q4 2020 and has held it in 23 quarters since.
  • Valmark Advisers's Gilead Sciences position peaked at $458K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Valmark Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.